| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 132.83B | 125.67B | 116.27B | 106.42B | 100.83B | 108.23B |
| Gross Profit | 17.53B | 17.33B | 17.31B | 16.23B | 14.63B | 14.06B |
| EBITDA | 6.52B | 6.53B | 5.44B | 4.73B | 3.49B | 3.93B |
| Net Income | 3.90B | 3.94B | 3.47B | 2.90B | 1.92B | 2.32B |
Balance Sheet | ||||||
| Total Assets | 80.08B | 89.78B | 86.46B | 83.85B | 79.04B | 77.81B |
| Cash, Cash Equivalents and Short-Term Investments | 19.99B | 16.72B | 17.05B | 15.34B | 19.37B | 17.16B |
| Total Debt | 569.00M | 139.00M | 836.00M | 60.00M | 132.00M | 91.00M |
| Total Liabilities | 32.58B | 41.79B | 38.25B | 39.47B | 33.47B | 33.30B |
| Stockholders Equity | 47.50B | 47.99B | 48.04B | 44.38B | 45.57B | 44.52B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 4.77B | 3.46B | -1.09B | 3.15B | -580.00M |
| Operating Cash Flow | 0.00 | 5.11B | 3.81B | -348.00M | 3.61B | -19.00M |
| Investing Cash Flow | 0.00 | -1.91B | -731.00M | 102.00M | -511.00M | 778.00M |
| Financing Cash Flow | 0.00 | -3.99B | -977.00M | -4.38B | -1.05B | -3.06B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
87 Outperform | ¥44.98B | 16.86 | ― | 3.48% | 18.42% | 51.06% | |
78 Outperform | ¥321.03B | 7.92 | 11.34% | 3.38% | 3.44% | 6.97% | |
73 Outperform | ¥105.82B | 10.14 | ― | 3.74% | -2.33% | -16.42% | |
73 Outperform | ¥382.91B | 9.25 | ― | 3.13% | 1.50% | 9.82% | |
69 Neutral | ¥474.46B | 14.68 | ― | 3.37% | 4.50% | -9.36% | |
68 Neutral | ¥105.64B | 9.91 | ― | 2.91% | 31.48% | 83.15% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |